ProKidney appoints EVP Technical Operations and SVP Global Clinical Operations

PROKIDNEY CORP.

Ulrich Ernst appointed EVP Technical Operations; base salary $450,000, target bonus 40%.
Ernst receives option for 500,000 Class A shares; 335,000 time-vesting, 165,000 performance-vesting.
Lucio Tozzi appointed SVP Global Clinical Operations on Jan 22, 2024; over 30 years experience.
Both executives join Leadership Team to support Phase 3 program and BLA preparation.
Ernst previously SVP at Iovance Biotherapeutics; Tozzi held senior roles at Summit Therapeutics.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ulrich Ernst

Executive Vice President, Technical Operations

PROK · PROKIDNEY CORP.

Effective: 2024-03-25
Filed: March 25, 2024, 7:59 PM ET

On March 25, 2024, ProKidney Corp. (the “Company”) announced the appointment of Ulrich Ernst, Ph.D. as the Company’s Executive Vice President, Technical Operations effective as of March 25, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ulrich Ernst was appointed as Executive Vice President, Technical Operations at PROKIDNEY CORP..

Action: appointed
Role: Executive Vice President, Technical Operations

Exact text from the filing

On March 25, 2024, ProKidney Corp. (the “Company”) announced the appointment of Ulrich Ernst, Ph.D. as the Company’s Executive Vice President, Technical Operations effective as of March 25, 2024.

View on SEC.gov

PROKIDNEY CORP. filing history →

Source: SEC EDGAR

accession 0000950170-24-035914

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.